Anaconda Biomed S.L.
PrivateLast Round
VC Round
Sep 23, 2026
Total Funding Raised
$50.56M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Anaconda Biomed S.L. operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a VC Round in September 2026.
Anaconda Biomed S.L. is a medical technology company that develops next-generation thrombectomy systems for the treatment of ischemic stroke.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anaconda Biomed S.L. Comparables
Compare Anaconda Biomed S.L. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vesalio | 92% | |
| Perfuze | 91% | |
| Ceretrieve | 90% |
For institutional investors. Book with your work email.
Anaconda Biomed S.L. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 23, 2026 | ||||
| VC Round | Jan 9, 2025 | ||||
| Debt | Oct 6, 2021 | ||||
| Series B | Dec 4, 2019 | ||||
| Grant | Aug 9, 2018 | ||||
Series A | May 22, 2017 |
For institutional investors. Book with your work email.
Anaconda Biomed S.L. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | VC Round, Series B |
| Omega Funds | Series B, Series A, VC Round |
| CDTI Innvierte | VC Round |
| Ysios Capital | VC Round, Series B, Series A |
| Innogest Capital | Series B, Series A |
| EIT Health | Grant |
| European Investment Bank Group | Debt |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2026
$56M round led by Omega Funds.
- Jun 11, 2025
Dr. Charles 'Chuck' Carignan appointed Chairman of the board.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 20, 2026
On Oct 20th '26, Anaconda raises €49 million to continue clinical development of new catheters for stroke treatment, including a funnel-shaped device that captures and removes clots while temporarily halting blood flow.
- expands_facilitiesSep 23, 2026
Anaconda expands facilities to Barcelona, Spain, Southern Europe, Europe.
- is_developingSep 23, 2026
Anaconda is developing a portfolio of products built on its Funnel Catheter platform for mechanical thrombectomy, aspiration-first stroke treatment and carotid interventions, including the ANA5, ANA6, ANA8 and Conda stent retriever.
- receives_financingSep 23, 2026
Anaconda closed a $56M financing round on Sep 23rd '26, led by Omega Funds with participation from new and existing investors in Spain and California, to support its ATHENA pivotal IDE study, product development, and global regulatory approvals.
For institutional investors. Book with your work email.
Anaconda Biomed S.L. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Anaconda Biomed S.L.'s valuation, stock price, and market status.
Is Anaconda Biomed S.L. a public or private company?
Anaconda Biomed S.L. is a private company.
What is the current stock price of Anaconda Biomed S.L.?
Anaconda Biomed S.L. is a private company, so its shares have no public market price. Caplight tracks Anaconda Biomed S.L.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Anaconda Biomed S.L. worth (valuation)?
Valuation information for Anaconda Biomed S.L. is not publicly available.
Can I buy Anaconda Biomed S.L. stock?
Anaconda Biomed S.L. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Anaconda Biomed S.L.'s last funding round?
Anaconda Biomed S.L.'s most recent funding round was VC Round on September 23, 2026.
Who are the main investors in Anaconda Biomed S.L.?
Key investors in Anaconda Biomed S.L. include Asabys Partners, Omega Funds, Ysios Capital, Innogest Capital.
Will Anaconda Biomed S.L. IPO soon?
No public IPO plans have been announced for Anaconda Biomed S.L..
How can I track Anaconda Biomed S.L. secondary market activity?
Caplight tracks bids, offers, and trades in Anaconda Biomed S.L.'s shares on secondary markets.